Denosumab is a new drug used to treat osteoporosis. One of its significant advantages is its ability to reduce the risk of fractures, especially in the hip and spine. Denosumab works by inhibiting the activity of osteoclasts, which reduces bone loss and strengthens the bones. Compared to traditional medications, it only needs to be injected once every six months, which is very convenient. Additionally, denosumab has shown better tolerability in some patients, with fewer side effects. Therefore, it is a good option for patients who cannot tolerate other medications.